Celia García-Malo

Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis

Diego García‐Borreguero, Xavier Guitart, Celia García-Malo et al. · Sleep Medicine · 2018 · 57 citations

Medicine, Neuropharmacology, Adenosine Hypothesis +4

A Randomized, Placebo‐Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome

Diego García‐Borreguero, Celia García-Malo, Juan José Granizo et al. · Movement Disorders · 2021 · 41 citations · Full text

Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment

Diego García‐Borreguero, Irene Cano‐Pumarega, Celia García-Malo et al. · Sleep Medicine · 2018 · 40 citations · Full text

Quantitative transcranial sonography of the substantia nigra as a predictor of therapeutic response to intravenous iron therapy in restless legs syndrome

Celia García-Malo, Vivian Wanner, Carolina Miranda et al. · Sleep Medicine · 2019 · 34 citations

Substantia Nigra, Clinical Neurology, Anesthesiology +6

Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome

Celia García-Malo, Sabela Novo-Ponte, Andrea Castro-Villacañas Farzamnia et al. · Sleep Medicine · 2021 · 13 citations

Clinical Disorders, Iron Metabolism, Physiology +5